Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease

Huntington disease is a neurodegenerative condition for which there is no cure to date. Activation of AMP-activated protein kinase has previously been shown to be beneficial in in vitro and in vivo models of Huntington’s disease. Moreover, a recent cross-sectional study demonstrated that treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchis, Ana, García-Gimeno, María Adelaida, Cañada-Martínez, Antonio José, Sequedo, María Dolores, Millán, José María, Sanz, Pascual, Vázquez-Manrique, Rafael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549163/
https://www.ncbi.nlm.nih.gov/pubmed/31165723
http://dx.doi.org/10.1038/s12276-019-0264-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549163/
https://www.ncbi.nlm.nih.gov/pubmed/31165723
http://dx.doi.org/10.1038/s12276-019-0264-9

Ejemplares similares